Sakane Y, Berry C, Hopkins M F, Singh K, Ghai R D
Research Department, Ciba-Geigy Corporation, Summit, NJ 07901.
Res Commun Chem Pathol Pharmacol. 1993 Aug;81(2):151-8.
Thiorphan was administered intravenously (i.v.) at 10 mg/kg to conscious rats in two different models of hypertension to allow a comparison of pharmacokinetics. The two models were: 1) Deoxycorticosterone acetate (DOCA)-salt uninephrectomized rats; 2) Spontaneously hypertensive rats (SHR), and their respective normotensive controls; 3) Sprague-Dawley (SD) rats; and 4) Wistar-Kyoto rats (WKY). Pharmacokinetic parameters were calculated for total and unbound thiorphan in plasma. In normotensive SD and WKY rats, the volume of distribution, clearance and plasma protein binding of thiorphan were not significantly different. Furthermore, the apparent elimination half-life was not significantly different for total or unbound thiorphan amongst all models. The volume of distribution and plasma clearance for both unbound and total thiorphan, however, were lower in DOCA-salt rats when compared to normotensive control rats by 61-66% and 46-51%, respectively. In contrast, pharmacokinetic parameters for both unbound and total thiorphan were not significantly different between SHR and WKY rats. These results indicate that reduced clearance of thiorphan in DOCA-salt rats may be due to the co-administration of DOCA-salt or altered renal function of the hypertrophic remaining kidney and not solely due to hypertension.
在两种不同的高血压模型中,以10mg/kg的剂量给清醒大鼠静脉注射硫喷妥,以比较其药代动力学。这两种模型分别是:1)醋酸脱氧皮质酮(DOCA)-盐单肾切除大鼠;2)自发性高血压大鼠(SHR)及其各自的正常血压对照;3)Sprague-Dawley(SD)大鼠;4)Wistar-Kyoto大鼠(WKY)。计算血浆中总硫喷妥和游离硫喷妥的药代动力学参数。在正常血压的SD和WKY大鼠中,硫喷妥的分布容积、清除率和血浆蛋白结合率无显著差异。此外,在所有模型中,总硫喷妥或游离硫喷妥的表观消除半衰期无显著差异。然而,与正常血压对照大鼠相比,DOCA-盐大鼠中游离硫喷妥和总硫喷妥的分布容积和血浆清除率分别降低了61-66%和46-51%。相比之下,SHR和WKY大鼠中游离硫喷妥和总硫喷妥的药代动力学参数无显著差异。这些结果表明,DOCA-盐大鼠中硫喷妥清除率降低可能是由于DOCA-盐的共同给药或肥大的残余肾脏肾功能改变,而不仅仅是由于高血压。